Effectiveness of Ashwagandha in Schizophrenia Patients on Risperidone

Clinical trial NCT07575516 · COMPLETED

Trial details

NCT number: NCT07575516
Sponsor: Hasanuddin University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Patients Neuroinflammation

Start date: 2025-10-01
Primary completion: 2026-01-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.